CORRA is an investigator-initiated , randomized , multicenter , double-blind , placebo-controlled trial with two treatment arms , starting with @ mg or @ mg prednisolone per day , tapered down to @ mg prednisolone within eight weeks , and one placebo arm , each arm comprising @ patients .